Evaluating the Impact of CYP3A5 Genotype on Post-Transplant Healthcare Resource Utilization in Pediatric Renal and Heart Transplant Recipients Receiving Tacrolimus.
Amy L PasternakVincent D MarshallChristina L GerschJames M RaeMichael EnglesbeJeong Mi ParkPublished in: Pharmacogenomics and personalized medicine (2021)
CYP3A5 genotype may predict healthcare resource utilization in the first year post-transplant, although this may be mitigated by differences in tacrolimus management. Future studies should evaluate the impact of genotype-guided dosing strategies for tacrolimus on healthcare utilization resources.